1. Home
  2. News
  3. Kangmei Pharmaceutical Co., Ltd
  4. Announcement on Progress in Litigation Involved
More Kangmei Pharmaceutical Co., Ltd news
Kangmei Pharmaceutical Co., LtdSSE: 600518

Announcement on Progress in Litigation Involved

Jul 21, 2026 · Issued by Kangmei Pharmaceutical Co., Ltd via Shanghai Stock Exchange

Filed with SSE · Jul 21, 2026 · 4 pages · Chinese

On 6ix: 6ix.com/news/kangmei-pharmaceutical-co-ltdannouncement-on-progress-in-litigation-involved

Kangmei Pharmaceutical Co., Ltd on 6ix

Earlier from Kangmei Pharmaceutical

  • Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jun 13
  • Announcement on Changing Business Scope and Amending the Articles of AssociationMay 27
  • Announcement on Resolutions of the 2025 Annual General MeetingMay 15
  • Report for Q1 2026Apr 30
  • Announcement on Resignation of DirectorApr 21

Later from Kangmei Pharmaceutical

  • Notice on Convening the 2nd Extraordinary General Meeting in 2026Aug 22
  • Announcement on Progress of Litigation Involved (II)Aug 26
  • Announcement on Convening the 2026 Semi-annual Performance BriefingSep 4
  • Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026Sep 8
  • (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 8th Extraordinary Meeting of the 10th Board of Directors in 2026Oct 29
All Kangmei Pharmaceutical news releases↗

Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.

Follow Kangmei Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer